Diffuse myocardial fibrosis as an SCD biomarker
- PMID: 36107457
- PMCID: PMC9479032
- DOI: 10.1182/blood.2022017725
Diffuse myocardial fibrosis as an SCD biomarker
Conflict of interest statement
Conflict-of-interest disclosure: The authors declare no competing financial interests.
Comment on
-
Early initiation of disease-modifying therapy can impede or prevent diffuse myocardial fibrosis in sickle cell anemia.Blood. 2022 Sep 15;140(11):1322-1324. doi: 10.1182/blood.2021015303. Blood. 2022. PMID: 35857896 Free PMC article.
References
-
- Hamideh D, Alvarez O. Sickle cell disease related mortality in the United States (1999-2009). Pediatr Blood Cancer. 2013;60(9):1482-1486. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
